Rocket Lab Hits Record High, but $3 Billion Share Offering Threatens to Dilute the Rally

Rocket Lab shares surged 8.2% to $135.76 after winning a $89.5M U.S. Space Force satellite contract, but a $3B equity offering caused a mid-week dip to $125 before rebounding amid strong analyst support.

The space contractor’s stock closed at $135.76 on Friday, an 8.2% daily gain and a 79% year-to-date advance, after the company secured an $89.5 million contract from the U.S. Space Force and successfully launched another satellite. Yet the week was far from a straight line upward — a $3 billion at-the-market equity offering announced mid-week sent shares sliding to $125 before they rebounded.

The Space Systems Command awarded Rocket Lab its first geostationary satellite production contract. The company will build two spacecraft equipped with Heimdall sensors for space situational awareness, using its Lightning satellite bus at the Long Beach facility. The deal, valued at $89.5 million, includes manufacturing, launch integration, and up to five years of on-orbit operations. It marks the direct payoff from Rocket Lab’s 2025 acquisition of optics specialist GEOST, which added advanced sensor capabilities to its vertically integrated model.

What soured the mood was the registration of an ATM program worth up to $3 billion, announced on May 20. Under the facility, Rocket Lab can issue new shares through brokers, with proceeds earmarked for growth initiatives, potential acquisitions, and general corporate purposes. The disclosure triggered a swift sell-off, as existing shareholders faced the prospect of their stakes being diluted. Three billion dollars is a staggering sum for a company with a market capitalization that has expanded rapidly, but management argues it is necessary to fund the next leap — particularly the Neutron rocket and expanding satellite programs.

The analyst community largely shrugged off the dilution concern. CFRA raised its price target to $140 and reiterated a buy, pointing to a backlog that has swelled past 70 missions. Deutsche Bank, TD Cowen, and Clear Street also lifted their targets after the Space Force win. Only KeyBanc remained cautious, noting that Rocket Lab’s forward price-to-sales multiple of 78 on 2026 revenue estimates far exceeds the sector average in the low-to-mid teens.

Cathie Wood’s ARK Invest, meanwhile, continued its pattern of trimming positions during rallies, selling 365,680 shares through its ETFs in May. The fund had done the same in November 2024, only to miss the subsequent surge. Whether this repeat sale will prove equally premature is open to debate, but the strong analyst support suggests confidence remains intact among many institutional observers.

The backdrop to the stock’s rally includes first-quarter results released earlier: revenue rose 64% year over year to just over $200 million, while the backlog hit a record $2.2 billion. The space systems segment — satellite construction and operations — now accounts for roughly 68% of total sales, and the new Space Force contract will tilt the mix even further toward the higher-margin systems business. Rocket Lab is still unprofitable, but investors are betting that the backlog and the upcoming Neutron rocket will eventually push the company into positive earnings.

Hours before the contract announcement, Rocket Lab executed its 88th Electron launch from New Zealand, carrying a StriX synthetic aperture radar satellite for Japanese Earth-observation customer Synspective. The mission, named “Viva La Strix,” marked the ninth flight for that operator, and the company has lined up 18 more launches through 2030 to build out Synspective’s constellation.

Attention now shifts to the first flight of the Neutron rocket, originally slated for 2025 but pushed to the end of 2026 after a tank test failure in January. Rocket Lab needs to deliver on that timeline to justify its valuation. For the current quarter, management guided revenue of $225 million to $240 million. The broader sector could also see capital flows shift if SpaceX eventually goes public, a possibility that might alter the competitive landscape.

For now, the stock sits at an all-time high, and the margin for error is razor-thin. Rocket Lab must sustain its growth trajectory while keeping dilution in check — a balancing act that will define whether the record rally has further to run or has already priced in too much optimism.